We are live on
!
Find out more
DVC
Deer VII & Co Portfolio holdings
AUM
$317M
1-Year Est. Return
30.89%
This Fund
S&P 500
This Quarter
Est. Return
+69.75%
1 Year Est. Return
+30.89%
3 Year Est. Return
+241.3%
5 Year Est. Return
+1,036.06%
10 Year Est. Return
–
AUM
$335M
AUM Growth
+$111M
(+49%)
Cap. Flow
-$2.12M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Protara Therapeutics
TARA
|
+$3.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLRN
Acceleron Pharma
XLRN
|
+$5.29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 64.9% |
| 2 | Healthcare | 35.01% |
| 3 | Communication Services | 0.1% |
Similar funds
DCM
TPCM
UTC
KCP
DMK
FA
HCIA
OH
Deer VII & Co's Q4 2014 Portfolio in Review
As of Q4 2014, Deer VII & Co held 8 positions worth $335M, up 49% from $224M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Deer VII & Co's Q4 2014 filing shows 1 new and 1 closed positions. Its largest new stake was Protara Therapeutics: 7,878 shares worth $2.95M. The largest sale was Acceleron Pharma, an estimated $5.29M.
By sector, the portfolio is most concentrated in Technology at 65% of assets, down from 75% a quarter earlier, followed by Healthcare and Communication Services.
- Deer VII & Co's largest Q4 2014 buy was Protara Therapeutics: 7,878 shares worth $2.95M.
- Deer VII & Co fully exited Acceleron Pharma in Q4 2014, selling an estimated $5.29M.
- Deer VII & Co's ten largest holdings make up 100% of its $335M portfolio in Q4 2014.
- Deer VII & Co opened 1 new position and closed 1 in Q4 2014.
- Deer VII & Co's portfolio value rose 49% quarter-over-quarter to $335M.
Based on Deer VII & Co's 13F filing for Q4 2014, filed 17 Feb 2015.